Imaging serotonergic neurotransmission in depression: Hippocampal pathophysiology may mirror global brain alterations

Biological Psychiatry

Volumn 48, Issue 8, 2000, Pages 801-812

  Fujita, Masahiro ^a,b,c   Charney, Dennis S ^a,b   Innis, Robert B ^a,b  

^a YALE UNIVERSITY   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

Corticosteroids; Drug effect; Emission tomography; Neurogenesis; Pindolol; Stress

Indexed keywords

ALTANSERIN; CARBON 11; CORTICOSTEROID; FLUORINE 18; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PINDOLOL; PRESYNAPTIC RECEPTOR; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN RECEPTOR; SETOPERONE;

BRAIN REGION; COGNITION; CONFERENCE PAPER; DEPRESSION; DRUG EFFECT; EMISSION TOMOGRAPHY; HUMAN; NERVOUS SYSTEM DEVELOPMENT; NEUROPATHOLOGY; NEUROTRANSMISSION; NONHUMAN; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR DENSITY; SEROTONINERGIC TRANSMISSION; STRESS;

ATROPHY; BRAIN; DEPRESSIVE DISORDER; HIPPOCAMPUS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; PITUITARY-ADRENAL SYSTEM; RECEPTORS, PRESYNAPTIC; RECEPTORS, SEROTONIN; SYNAPTIC TRANSMISSION; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0034667297     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(00)00960-4     Document Type: Conference Paper

References (103)

1. 123I]ODAM
2. Pindolol binding to 5-HT1A receptors in the human brain confirmed with positron emission tomography
3. Urinary free cortisol in psychotic depression
4. Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims
5. Postmortem findings in suicide victims. Implications for in vivo imaging studies
6. 18F]-setoperone during depressive illness and antidepressant treatment with clomipramine
7. 18F]altanserinol
8. Fluoxetine: A review of receptor and functional effects and their clinical implications
9. Effect of pindolol in hastening responses to fluoxetine in the treatment of major depression: A double-blind placebo-controlled trial
10. Serotonin 5-HT2 receptor imaging in major depression: Focal changes in orbito-insular cortex
11. Current advances and trends in the treatment of depression
12. Possible serotonergic mechanisms underlying the antidepressant and anti-obsessive-compulsive disorder responses
13. In vivo regulation of intraneuronal trafficking of G protein-coupled receptors for neurotransmitters
14. Effect of pindolol on onset of action of paroxetine in the treatment of major depression: Intermediate analysis of a double-blind, placebo-controlled trial
15. Evidence that chronic administration of paroxetine or fluoxetine enhances 5-HT2 receptor function in the brain of the guinea pig
16. Restoring production of hippocampal neurons in old age
17. Differentiation of newly born neurons and glia in the dentate gyrus of the adult rat
18. A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility
19. 18F]FCWAY, an analog of the 5-HT(1A) antagonist WAY 100635
20. Regulation of hippocampal 5-HT1A receptor gene expression by dexamethasone
21. Serotonin concentrations and turn-over in brains of depressed suicides
22. A role for 5-HT in the action of antidepressant drugs
23. 3H]paroxetine binding and serotonin content of rat cortical areas, hippocampus, neostriatum, ventral mesencephalic tegmentum, and midbrain raphe nuclei region following p-chlorophenylalanine and p-chloroamphetamine treatment
24. PET imaging of serotonin 1A receptor binding in depression
25. Regulation of central 5-HT2A receptors: A review of in vivo studies
26. Is platelet imipramine binding reduced in depression? A meta-analysis
27. Neurogenesis in the adult human hippocampus
28. Participation of the dorsal hippocampus in the glucocorticoid feedback effect on adrenocortical activity
29. A pharmacological profile of WAY-100635, a potent and selective 5-HT(1A) receptor antagonist
30. The dexamethasone suppression test: An overview of its current status in psychiatry. The APA Task Force on Laboratory Tests in Psychiatry
31. Proliferation of granule cell precursors in the dentate gyrus of adult monkeys is diminished by stress
32. 11C]WAY-100635 for PET
33. Reduced central serotonin transporters in alcoholism
34. PET examination of three potent cocaine derivatives as specific radioligands for the serotonin transporter
35. Serotonin stimulates the production of new hippocampal granule neurons via the 5HT1A receptor in the adult rat
36. The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis
37. Iodine-123-5-iodo-6-nitroquipazine: SPECT radiotracer to image the serotonin transporter
38. Mineralocorticoid hormones suppress serotonin-induced hyperpolarization of rat hippocampal CA1 neurons
39. Long-term exposure to high corticosterone levels attenuates serotonin responses in rat hippocampal CA1 neurons
40. Pituitary size in depression
41. 123I]IDAM as a novel single-photon emission tomography tracer for serotonin transporters
42. Simplified reference tissue model for PET receptor studies
43. The development of F-18 labeled, reversible 5-HT(1A) silent antagonists with polar metabolites
44. 123I]β-CIT: Pharmacological characterization of brain uptake in nonhuman primates
45. Regulation of serotonin 1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: Implications for the neurobiology of depression
46. Serotonin 1A receptor messenger RNA regulation in the hippocampus after acute stress
47. 5-HT1A receptor binding sites in post-mortem brain samples from depressed suicides and controls
48. Characterization of bromine-76-labelled 5-bromo-6-nitroquipazine for PET studies of the serotonin transporter
49. The serotonin hypothesis of major depression
50. Chronic stress alters synaptic terminal structure in hippocampus
51. Corticosterone regulation of serotonin transporter and 5-HT1A receptor expression in the aging brain
52. Chronic antidepressant administration increases granule cell genesis in the hippocampus of the adult male rat
53. 123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography
54. Attempted suicide characteristics and cerebrospinal fluid amine metabolites in depressed inpatients
55. Positron emission tomography study of pindolol occupancy of 5-HT(1A) receptors in humans: Preliminary analyses
56. Serotonergic measures in suicide brain: 5-HT1A binding sites in frontal cortex of suicide victims
57. Mood and neuropsychological function in depression: The role of corticosteroids and serotonin
58. Paradoxical effects of adrenal steroids on the brain: Protection versus degeneration
59. Corticosterone and serotonergic neurotransmission in the hippocampus: Functional implications of central corticosteroid receptor diversity
60. Elevated basal trough levels of corticosterone suppress hippocampal 5-hydroxytryptamine(1A) receptor expression in adrenally intact rats: Implication for the pathogenesis of depression
61. PET imaging of serotonin type 2A receptors in late-life neuropsychiatric disorders
62. 3H]8-hydroxy-2-(di-n-propylamino)tetralin binding at 5-HT1A receptors in the medial preoptic nucleus of the castrated male rat
63. 18F]-setoperone PET
64. 18F]setoperone PET imaging study
65. Steroids and depression
66. The corticotropin-releasing factor (CRF) hypothesis of depression: New findings and new directions
67. Correlation between the dexamethasone suppression test in depressed patients and clinical response
68. Adrenal gland enlargement in major depression. A computed tomographic study
69. Characterization of the radioactive metabolites of the 5-HT1A receptor radioligand, [O-methyl-11C]WAY-100635, in monkey and human plasma by HPLC: Comparison of the behaviour of an identified radioactive metabolite with parent radioligand in monkey using PET
70. 11C]WAY-100635 - Explanation of high signal contrast in PET and an aid to biomathematical modeling
71. Serotonergic mechanisms in brains of suicide victims
72. Alterations in phosphoinositide signaling and G-protein levels in depressed suicide brain
73. 11C]carbonyl-WAY 100635 and endogenous serotonin
74. Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment
75. A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors
76. 11C]Desmethyl-WAY-100635 (DWAY) is a potent and selective radioligand for central 5-HT(1A) receptors in vitro and in vivo
77. β-Blocker binding to human 5-HT(1A) receptors in vivo and in vitro. Implications for antidepressant therapy
78. Blockade of 5HT1A receptors prevents hippocampal granule cell genesis during and after pilocarpine-induced status epileptics
79. Hypothalamic-pituitary-adrenal axis activity and 1-year outcome in depression
80. The dexamethasone suppression test in patients with mood disorders
81. Disrupted 24-hour patterns of cortisol secretion in psychotic depression
82. Why stress is bad for your brain
83. Glucocorticoid-sensitive hippocampal neurons are involved in terminating the adrenocortical stress response
84. Hippocampal damage associated with prolonged glucocorticoid exposure in primates
85. 11C]WAY-100635: Effects of depression and antidepressant treatment
86. 11C]-WAY 100635 in depressed patients before and after SSRI treatment
87. Cortical grey matter reductions associated with treatment-resistant chronic unipolar depression. Controlled magnetic resonance imaging study
88. Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression
89. Imaging of the serotonergic system: Interactions of neuroanatomical and functional abnormalities of depression
90. Serotonin receptors in suicide victims with major depression
91. Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression-postmortem evidence for decreased serotonin activity
92. 18F]fluoroethyl analog of McN5652
93. A PET radiotracer for studying serotonin uptake sites: Carbon-11-McN-5652Z
94. Application of the deuterium isotope effect to enhance PET signal by impeding tracer metabolism: Synthesis of deuterium and fluorine-18 dual-labeled altanserin and its nitro precursor
95. 18F]altanserin in human and rodent
96. Morphometry of the dorsal raphe nucleus serotonergic neurons in suicide victims
97. Brain damage induced by prenatal exposure to dexamethasone in fetal rhesus macaques. I. Hippocampus
98. Hippocampal damage associated with prolonged and fatal stress in primates
99. 18F]altanserin
100. Tianeptine attenuates stress-induced morphological changes in the hippocampus
101. Exposure to excess glucocorticoids alters dendritic morphology of adult hippocampal pyramidal neurons
102. Decrease in brain serotonin 2 receptor binding in patients with major depression following desipramine treatment: A positron emission tomography study with fluorine-18-labeled setoperone
103. How long should pindolol be associated with paroxetine to improve the antidepressant response?